CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
7 research outputs found
A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI).
Author
Azeez Farooki
Clifford A. Hudis
+6Â more
David B. Page
Didier Hans
Monica Nancy Fornier
Oksana Davydov
Sujata Patil
Veronica Mariotti
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
Author
Andrew D. Seidman
Bear
+45Â more
Bonadonna
Bonnadonna
Bonnadonna
Bonnadonna
Carolyn Wasserheit-Lieblich
Cheang
Citron
Clifford Hudis
Coiffier
Colleoni
Colleoni
Deena Atieh-Graham
Diana Lake
Fornier
Fornier
Gabriella D'Andrea
Gianni
Gilewski
Halaas
Hamangi Patel
Hudis
Hudis
Jeffrey Yuan
Kolb
Larry Norton
Lindeman
McArthur
Monica N. Fornier
Nancy Mills
Nancy Sklarin
Norton
Pamela Drullinsky
Rueda
Singletary
Skipper
Steven M. Sugarman
Sugarman
Sujata Patil
Tancini
Tannock
Teresa Gilewski
Tiffany Traina
Tiffany Troso-Sandoval
Womer
Wood
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).
Author
Alex Morozov
Alexia Iasonos
+17Â more
Christina Marie Coughlin
Clifford A. Hudis
Gary Ulaner
Jose Baselga
Joy Ero
Mary Ellen Moynahan
Maura N. Dickler
Michael F. Berger
Monica Nancy Fornier
Nancy T. Sklarin
Neal Rosen
Payal Deepak Shah
Sarat Chandarlapaty
Shanu Modi
Stephen James Zamora
Teresa Gilewski
Valentina Sterlin
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).
Author
Angemael Syldor
Chau T. Dang
+18Â more
Clifford Hudis
Conleth G. Murphy
Devika Gajria
Diana Lake
Elizabeth Anne Comen
Farrah Mikhail Datko
Gabriella D'Andrea
Jennifer Liu
Julie Fasano
Maria Theodoulou
Maura N. Dickler
Monica Nancy Fornier
Nancy T. Sklarin
Pamela Drullinsky
Sarat Chandarlapaty
Shanu Modi
Shari Beth Goldfarb
Sujata Patil
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC).
Author
Chau T. Dang
Clifford A. Hudis
+18Â more
Devika Gajria
Diana Lake
Elizabeth Anne Comen
Gabriella D'Andrea
Jose Baselga
Julie Fasano
Larry Norton
Maria Theodoulou
Melanie Chen
Monica Nancy Fornier
Neil M. Iyengar
Pamela Drullinsky
Shanu Modi
Shari Beth Goldfarb
Steven Sugarman
Sujata Patil
Tiffany A. Traina
Tiffany A. Troso-Sandoval
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2
Author
Andrew D. Seidman
Ariadne Bach
+20Â more
Clifford A. Hudis
Crispinita Arroyo
Edgardo Rivera
Francisco J. Esteva
Gabriel N. Hortobagyi
Gabriella D’Andrea
Katherine S. Panageas
Larry Norton
Lee Tan
Maria Theodoulou
Mark Moasser
Mary Ellen Moynahan
Massimo Cristofanilli
Maura Dickler
Monica N. Fornier
Nancy Sklarin
Stamatina Kaptain
Teresa Gilewski
Vicente Valero
Violante Currie
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer
Author
Aitken
Andrew Seidman
+37Â more
Benjamin Nulsen
Carmen Merali
Chau Dang
Clifford A. Hudis
Diana Lake
Gabriella D'Andrea
Heather L. McArthur
Hope Rugo
Hudis
Jane E. Sealey
Jill Grothusen
John H. Laragh
John Park
Larry Norton
Laura Hawks
Maria Theodoulou
Mark Moasser
Mark Robson
Mary Ellen Moynahan
Matthew Paulson
Maura N. Dickler
Michelle Melisko
Monica Fornier
Monica Morrow
Nancy Sklarin
Naumov
Peter Cordeiro
Qin Zhou
Richard Steingart
Sato
Sealey
Shanu Modi
Steven Sugarman
Sujata Patil
Theresa Gilewski
Tiffany Traina
Weiss
Publication venue
'American Association for Cancer Research (AACR)'
Publication date
Field of study
No full text
Crossref